ALSO NOTED: Glenmark buys Czech drug maker; Simcere files for IPO;and much more...

> Looking for a European beachhead for Europe's branded drug market, India's Glenmark has agreed to acquire a majority interest in the Czech drug company Medicamenta. Report

> China's generic drug maker Simcere Pharma has filed for a $120 million IPO. Report

> Alexza Pharmaceuticals says that mid-stage trials of its inhalable schizophrenia and migraine drug demonstrated positive results. AZ-004 demonstrated reduced agitation in schizophrenia patients while all three doses of AZ-001 reduced migraine pain in two hours compared to a placebo. Release

> Israel's BioLineRx has signed in-license agreements to develop and commercialize two new therapeutic candidates: BL-3040, a small molecule for the treatment of estrogen-regulated malignancies and osteoporosis; and BL-3050, a protein complex for the treatment of atherosclerosis. Release

> Endocyte, a biotech developing treatments for cancer and autoimmune diseases, announced Friday that it has completed a $15 million round of venture financing. Release

And Finally... Germany and Italy have joined a growing list of European countries recommending the universal use of the HPV vaccine Gardasil for girls aged 12 to 17. Report